MMI (Medical Microinstruments)

[PRIVATE]

Service & Cobot Robotics · HQ: Jacksonville, Florida · Est. 2015 · 1 model registered · 2 deployments

New deploymentFunding gap >24mo

As of Sep 2026, DEPLOY verifies MMI (Medical Microinstruments): 1 model, 2 deployments across 2 regions, $211.0M raised. 1 source back the record.

Ownership

PRIVATE

Capital / Funding

$211M

Headquarters

Jacksonville, Florida

IP / Patents

Undisclosed

Platform Models

1

Audited Incidents

0

Overview

Italian-founded surgical robotics company developing the Symani Surgical System, the first robotic platform for open soft-tissue microsurgery. MMI's NanoWrist instruments are the world's smallest wristed surgical robotic instruments, enabling tremor filtration and motion scaling for procedures on vessels as small as 0.3mm. Founded in 2015 near Pisa, Italy, MMI received FDA De Novo authorization in April 2024 and CE mark in 2019, with ~1,000 clinical cases completed in Europe.

Audited Posture AssessmentPeer Percentile: 79.7%

Clean safety record across 2 verified deployments. Limited public visibility and press coverage relative to peers.

  • SURGICAL

Key Facts

CEOMark Toland
Founded2015 near Pisa, Italy
HQJacksonville, Florida (US redomicile 2022); R&D and manufacturing in Pisa, Italy
ProductSymani Surgical System — robotic microsurgery platform with NanoWrist instruments (world's smallest wristed surgical robotic instruments, 7 DOF, tremor filtration, motion scaling)
FDA statusFDA De Novo Authorization (April 2024) — only commercially available platform in the U.S. for reconstructive microsurgery
CE markReceived CE mark in Europe (2019); commercially available in Europe and parts of Asia Pacific
Clinical cases~1,000 clinical cases in the EU; first U.S. clinical cases completed in 2024
Funding>$200M total ($2M seed 2016, $24M Series A 2018, $75M Series B 2022, $110M Series C 2024)
Financial stageGrowth — commercial stage with FDA authorization, expanding globally
ManufacturingSymani manufactured in Pisa, Italy
Key investorsFidelity Management & Research Company (Series C lead), Deerfield Management (Series B lead), RA Capital, Andera Partners, Fountain Healthcare, Panakès Partners, Wellington Partners
REMIND studyFirst robotic microsurgical study in Alzheimer's patients (IDE approved Nov 2025, first patient treated May 2026)

Safety & Regulatory Posture

0 entries
Audited Incident & Recall Footprint

No incidents on record for MMI (Medical Microinstruments).

Leadership & Founders

1 entry

Current Program Leadership & Executives

Mark TolandSEC-verified

CEO

Partnerships & Commercial Deployments

2 entries
Total Tracked0
Operating0
Announced0
Concluded0

Operator Customers & Fleet Integrators

MMI (Medical Microinstruments) - 2 deploymentsMMI (Medical Microinstruments)

Platform Models

1 entry

Deployments

2 entries

Sectors & Applications

1 entry

FAQ

13 entries
What is MMI (Medical Microinstruments)?

Italian-founded surgical robotics company developing the Symani Surgical System, the first robotic platform for open soft-tissue microsurgery. MMI's NanoWrist instruments are the world's smallest wristed surgical robotic instruments, enabling tremor filtration and motion scaling for procedures on vessels as small as 0.3mm. Founded in 2015 near Pisa, Italy, MMI received FDA De Novo authorization in April 2024 and CE mark in 2019, with ~1,000 clinical cases completed in Europe.

What does MMI (Medical Microinstruments) make?

MMI (Medical Microinstruments) has 1 robot model on the DEPLOY registry: Symani Surgical System (MMI (Medical Microinstruments) builds physical robots).

Is MMI (Medical Microinstruments) publicly traded?

No. MMI (Medical Microinstruments) is privately held and not publicly traded, per the DEPLOY registry.

Who competes with MMI (Medical Microinstruments)?

On the DEPLOY registry, peer companies to MMI (Medical Microinstruments) building in the same form factors include Brainlab, EndoQuest Robotics, Intuitive Surgical, LEM Surgical.

Who is the CEO of MMI (Medical Microinstruments)?

Mark Toland is the ceo of MMI (Medical Microinstruments), per the DEPLOY registry.

How can I invest in MMI (Medical Microinstruments)?

MMI (Medical Microinstruments) is a private company; its shares are not available on public markets, so retail investors cannot buy the stock today. It has raised $211M in disclosed funding.

Where is MMI (Medical Microinstruments) headquartered?

MMI (Medical Microinstruments) is headquartered in Jacksonville, Florida, USA.

How much funding has MMI (Medical Microinstruments) raised?

MMI (Medical Microinstruments) has raised approximately $211M in disclosed funding on record in the DEPLOY registry.

Who owns MMI (Medical Microinstruments)?

MMI (Medical Microinstruments) is privately held and venture-backed ($211M raised); ownership sits with its founders and private investors.

Where does MMI (Medical Microinstruments) operate robots?

MMI (Medical Microinstruments) operates 2 verified deployments, including at Tampa, FL, Florence, Italy.

How many robots has MMI (Medical Microinstruments) deployed?

DEPLOY has 2 verified MMI (Medical Microinstruments) deployments on record at sites including Tampa, FL, Florence, Italy. That is a count of distinct field deployments each backed by sourced evidence, not a manufacturer's claimed unit total; it updates as new sites are verified.

Is MMI (Medical Microinstruments) a top robotics company?

On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, MMI (Medical Microinstruments) ranks in roughly the top 21% of companies tracked by the registry.

Is MMI (Medical Microinstruments) safe?

MMI (Medical Microinstruments) has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.